SCHEMBL9200428

SCHEMBL9200428

CC(N)NC(=O)c1ccco1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.59
ALDH1A1 P00352 4/20 0.58
TP53 P04637 2/20 0.56
LMNA P02545 3/20 0.55
GAA P10253 2/20 0.55
MAPT P10636 1/20 0.53
POLB P06746 3/20 0.51
ALOX15 P16050 1/20 0.51
HSD17B10 Q99714 1/20 0.51
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1106975 0.85 KMT2A (0.62) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL8338185 0.83 KMT2A (0.56) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL18906021 0.81 KMT2A (0.61) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL15743809 0.81 KMT2A (0.57) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL21041221 0.79 KMT2A (0.68) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL24882693 0.78 KMT2A (0.55) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL27281106 0.78 ALDH1A1 (0.62) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL18546466 0.78 ALDH1A1 (0.62) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL23801582 0.77 KMT2A (0.57) KMT2AALDH1A1TP53LMNAGAA
SCHEMBL14664119 0.77 KMT2A (0.54) KMT2AALDH1A1TP53LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520883-B1 2-Aminopyrimidin-4-carboxamide derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1995-07-12 EP disclosed
US-5244894-A Treating disorders involving hyperactivity of the alpha 1-adrenergic system in lower urinary tract SYNTHELABO 1993-09-14 US disclosed
EP-0520883-A1 2-Aminopyrimidin-4-carboxamide derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1992-12-30 EP disclosed